GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invent Medic Sweden AB (XSAT:IMS) » Definitions » Cash Flow from Financing

Invent Medic Sweden AB (XSAT:IMS) Cash Flow from Financing : kr7.41 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Invent Medic Sweden AB Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2024, Invent Medic Sweden AB paid kr0.00 Mil more to buy back shares than it received from issuing new shares. It received kr0.00 Mil from issuing more debt. It paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received kr0.00 Mil from paying cash dividends to shareholders. It received kr0.00 Mil on other financial activities. In all, Invent Medic Sweden AB spent kr0.00 Mil on financial activities for the three months ended in Dec. 2024.


Invent Medic Sweden AB Cash Flow from Financing Historical Data

The historical data trend for Invent Medic Sweden AB's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invent Medic Sweden AB Cash Flow from Financing Chart

Invent Medic Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only 25.15 23.67 0.38 9.70 7.41

Invent Medic Sweden AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.42 1.86 0.87 0.81 3.87

Invent Medic Sweden AB Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Invent Medic Sweden AB's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:

Invent Medic Sweden AB's Cash from Financing for the quarter that ended in Dec. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr7.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invent Medic Sweden AB  (XSAT:IMS) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Invent Medic Sweden AB's issuance of stock for the three months ended in Dec. 2024 was kr0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Invent Medic Sweden AB's repurchase of stock for the three months ended in Dec. 2024 was kr0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Invent Medic Sweden AB's net issuance of debt for the three months ended in Dec. 2024 was kr0.00 Mil. Invent Medic Sweden AB received kr0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Invent Medic Sweden AB's net issuance of preferred for the three months ended in Dec. 2024 was kr0.00 Mil. Invent Medic Sweden AB paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Invent Medic Sweden AB's cash flow for dividends for the three months ended in Dec. 2024 was kr0.00 Mil. Invent Medic Sweden AB received kr0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Invent Medic Sweden AB's other financing for the three months ended in Dec. 2024 was kr0.00 Mil. Invent Medic Sweden AB received kr0.00 Mil on other financial activities.


Invent Medic Sweden AB Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Invent Medic Sweden AB's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Invent Medic Sweden AB Business Description

Traded in Other Exchanges
N/A
Address
Nytenkargatan 4, Lund, SWE, 223 63
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.

Invent Medic Sweden AB Headlines

From GuruFocus

The Big 3: Larry Robbins' Top 2nd-Quarter Buys

By James Li James Li 08-16-2016

Healthcare Informatics: A Value Investor's Perspective

By Thomas Macpherson Thomas Macpherson 10-23-2015

Well-Known Companies Reach 52 Week Highs

By yifan900 yifan900 10-11-2016

5 Companies Reach 52-Week Highs

By yifan900 yifan900 02-13-2018

Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

By James Xiao James Xiao 08-11-2015